Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: Role of prostaglandin

World Journal of Gastroenterology

Volumn 12, Issue 15, 2006, Pages 2351-2356

  Lay, Chii Shyan ^a   May, C M Y ^b   Lee, Fa Yauh ^b   Tsai, Yang Te ^b   Lee, Shou Dong ^b   Chien, Shu ^c   Sinchon, Shlomoh ^d  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d New York University Medical Center ^*  (United States)

Author keywords

Nitric oxide synthase; Portal hypertension; Verapamil

Indexed keywords

INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; HEART OUTPUT; HEMODYNAMICS; MALE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; RAT; VASCULAR RESISTANCE; VEIN LIGATION;

EID: 33646460481     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i15.2351     Document Type: Article

References (29)

1. Singh BN, Ellrodt G, Peter CT. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 1978; 15: 169-197
2. Dacquet C, Mironneau C, Mironneau J. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein. Br J Pharmacol 1987; 92: 203-211
3. Freeman JG, Barton JR, Record CO. Effect of isosorbide dinitrate, verapamil, and labetalol on portal pressure in cirrhosis. Br Med J (Clin Res Ed) 1985; 291: 561-562
4. Kong CW, Lay CS, Tsai YT, Yeh CL, Lai KH, Lee SD, Lo KJ, Chiang BN. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis. Hepatology 1986; 6: 423-426
5. Lay CS, Tsai YT, Lo KJ, Lee SD, Chen TS, Lee FY. Medical treatments for bleeding esophageal varices. Hepatology 1987; 7: 208
6. Reichen J, Le M. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest 1986; 78: 448-455
7. Reichen J, Hirlinger A, Ha HR, Sagesser S. Chronic verapamil administration lowers portal pressure and improves hepatic function in rats with liver cirrhosis. J Hepatol 1986; 3: 49-58
8. Navasa M, Bosch J, Reichert J, Bru C, Mastai R, Zysset T, Silva G, Chesta J, Rodes J. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Hepatology 1988; 8: 850-854
9. Garcia-Pagan JC, Feu F, Luca A, Fernandez M, Pizcueta P, Bosch J, Rodes J. Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis. J Hepatol 1994; 20: 792-796
10. Koshy A, Hadengue A, Lee SS, Jiron MI, Lebrec D. Possible deleterious hemodynamic effect of nifedipne on portal hypertension in patients with cirrhosis. Clin Pharmacol Ther 1987; 42: 295-298
11. Casadevall M, Panes J, Pique JM, Marroni N, Bosch J, Whittle BJ. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 1993; 18: 628-634
12. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology 1993; 18: 1416-1421
13. Theodorakis NG, Wang YN, Skill NJ, Metz MA, Cahill PA, Redmond EM, Sitzmann JV. The role of nitric oxide synthase isoforms in extrahepatic portal hypertension: studies in gene-knockout mice. Gastroenterology 2003; 124: 1500-1508
14. Lee FY, Colombato LA, Albillos A, Groszmann RJ. Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats. Gastroenterology 1993; 105: 1464-1470
15. Chan CC, Lee FY, Wang SS, Chang FY, Lin HC, Chu CJ, Tai CC, Lai IN, Lee SD. Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 1999; 30: 630-635
16. Mosca P, Lee FY, Kaumann AJ, Groszmann RJ. Pharmacology of portal-systemic collaterals in portal hypertensive rats: role of endothelium. Am J Physiol 1992; 263: G544-G550
17. Graupera M, March S, Engel P, Rodes J, Bosch J, Garcia-Pagan JC. Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers. Am J Physiol Gastrointest Liver Physiol 2005; 288: G763-G770
18. Hou MC, Cahill PA, Zhang S, Wang YN, Hendrickson RJ, Redmond EM, Sitzmann JV. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: role in the hyperdynamic circulation. Hepatology 1998; 27: 20-27
19. Chan CC, Wang SS, Lee FY, Chang FY, Lin HC, Chu CJ, Chen CT, Huang HC, Lee SD. Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats. Hepatology 2001; 33: 816-820
20. Lay CS, Tsai YT, Yang CM, Chen HI, Simchon S, Chien S, Lo KJ. Effect of verapamil on splanchnic haemodynamics in a portal hypertensive rat model. J Gastroenterol Hepatol 1990; 5: 141-148
21. Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol 1981; 240: G371-G375
22. Lay CS, Tsai YT, Kong CW, Lee FY, Chang TT, Lin HC, Yang CM, Lee SD, Chiang BN, Lo KJ. The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascites. Clin Pharmacol Ther 1988; 44: 453-457
23. Bataller R, Gasull X, Gines P, Hellemans K, Gorbig MN, Nicolas JM, Sancho-Bru P, De Las Heras D, Gual A, Geerts A, Arroyo V, Rodes J. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 2001; 33: 956-962
24. Hamann SR, Blouin RA, McAllister RG Jr. Clinical pharmacokinetics of verapamil. Clin Pharmacokinet 1984; 9: 26-41
25. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103: 235-239
26. Pizcueta MP, Pique JM, Bosch J, Whittle BJ, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184-190
27. Niederberger M, Martin PY, Gines P, Morris K, Tsai P, Xu DL, McMurtry I, Schrier RW. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995; 109: 1624-1630
28. Pizcueta P, Pique JM, Fernandez M, Bosch J, Rodes J, Whittle BJ, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 1909-1915
29. Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Choo K, Sessa WC, Groszmann RJ. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology 1999; 117: 1222-1228